tirzepatide being pulled FDA says this weight loss drug shortage is over, but patients worry about cost and availability As Eli Lilly, compounders battle

Compared to tirzepatide based therapies such as ZepBound or Mounjaro, Ozempic may yield slower or less dramatic weight loss in some individuals, but remains one of the most versatile and widely used GLP-1 medications available

Have a maintenance plan Successful patients dont just stop. They transition into a maintenance phase with continued coaching, monitoring, and accountability

This mechanism of action, according to Amgen, not only induces weight loss during treatment but also lowers the likelihood of weight regain after dosing ends

#WomensHealth #OvarianHealth #PatientEducation #MedicalResearch #HealthcareAdvocacy To view or add a comment, sign in Late postbut better at the end than not at all

The drug, approved by the U.S